Doctors Testing Gout Treatment As Coronavirus Therapeutic

While coronavirus vaccine news has dominated recent pandemic coverage, there is an update on the treatment front as well.

U.K. researchers leading the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial which involves hospitalized coronavirus patients have announced that they will begin testing a drug commonly used to treat gout and other inflammatory conditions.

“Colchicine is an attractive drug to evaluate in the RECOVERY trial as it is very well understood, inexpensive and widely available,” professor Peter Horby, co-chief investigator of the RECOVERY trial, said in a news release. “If it works it would be another COVID-19 treatment that could be used immediately worldwide, even in the poorest countries.”

Read more at Fox News.

{Matzav.com}